Colorectal Cancer Screening Blood Test Approved by FDA
-
By
-
Kathryn Wighton
-
July 27, 2026
-
2 min
By
Kathryn Wighton
July 27, 2026
An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.
July 20, 2026
The differences were present before patients began any treatment, suggesting quality-of-life gaps may be established before therapy begins.
June 22, 2026